Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Article in German | MEDLINE | ID: mdl-35235959

ABSTRACT

OBJECTIVE: Epilepsy is one of the more common chronic neurological diseases in cats in which MRI plays a key role in the diagnostic work-up. Hippocampal MRI changes are common in cats, however it is unclear whether these changes represent the reason or the consequence of the disease.The goal of the present study was the retrospective analysis of the MRI findings in a large cohort of epileptic cats. MATERIAL AND METHODS: In total, 143 cats of 3 age groups (< 1 year, 1-6 years, and > 6 years) were included in the study. MRI findings were divided into 4 categories: normal, with extrahippocampal lesions, and hippocampal signal alterations with or without contrast enhancement. The prevalence and frequency of these MRI findings in the age groups were examined using chi-quadrat test and nominal regression model. RESULTS: In approximately one half of the cats (49 %), MRI displayed normal findings. Extrahippocampal changes occurred in 18 % of the animals. Hippocampal alterations were present in 33 % of the cats. Hippocampal sclerosis was found histopathologically in all four MRI categories. CONCLUSION AND CLINICAL RELEVANCE: Brain MRI was normal in approximately 50 % of the epileptic cats. Extrahippocampal changes are expected mostly in cats older than 6 years. The etiology of the hippocampal alterations is unclear in most cases. Further investigations are needed for a better understanding of the hippocampal signal alterations.


Subject(s)
Cat Diseases , Epilepsy , Animals , Cat Diseases/diagnostic imaging , Cat Diseases/pathology , Cats , Epilepsy/diagnostic imaging , Epilepsy/veterinary , Hippocampus/diagnostic imaging , Magnetic Resonance Imaging/methods , Magnetic Resonance Imaging/veterinary , Prevalence , Retrospective Studies
2.
J Feline Med Surg ; 24(6): 565-579, 2022 06.
Article in English | MEDLINE | ID: mdl-34493101

ABSTRACT

OBJECTIVES: The aim of this study was to determine the prevalence of post-contrast acute kidney injury or comparable side effects on kidney function in cats receiving the non-ionic, iodinated agent ioversol and/or paramagnetic agent gadoteric acid. METHODS: Fifty-two animals were divided into four groups on the basis of contrast medium administration for imaging: ioversol (n = 27), gadoteric acid (n = 12), dual contrast media (n = 4) or control, which received an infusion of isotone intravenous fluids only during anaesthesia (n = 9). Blood and urine samples were obtained three times after contrast administration and compared with values obtained prior to administration of the contrast medium. Creatinine (<1.60 mg/dl), symmetric dimethylarginine (SDMA; ⩽14 µg/dl), urine protein:creatinine ratio (UPC; <0.2) and critical differences for creatinine (<0.3 mg/dl) and SDMA (<5.98 µg/dl) were measured. RESULTS: No significant short-term effects on mean creatinine, SDMA and UPC measurements were seen. Borderline proteinuria (UPC, 0.2-0.4) was detected in 11.4% of cases after contrast media administration. A UPC of more than 0.2 in five cases indicated that contrast media may affect kidney function, leading to (transient) proteinuria. CONCLUSIONS AND RELEVANCE: This study found no side effect on renal function following the administration of ioversol or gadoteric acid, provided patients were adequately hydrated. However, the clinical relevance of proteinuria in some cats needs to be evaluated in future studies.


Subject(s)
Acute Kidney Injury , Azotemia , Cat Diseases , Renal Insufficiency, Chronic , Acute Kidney Injury/veterinary , Animals , Azotemia/chemically induced , Azotemia/veterinary , Biomarkers , Cat Diseases/chemically induced , Cats , Contrast Media/adverse effects , Creatinine , Kidney/diagnostic imaging , Kidney/physiology , Proteinuria/veterinary , Renal Insufficiency, Chronic/veterinary
3.
Eur J Neurosci ; 24(2): 555-63, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16903857

ABSTRACT

Long-term depression (LTD) is one of the paradigms used in vivo or ex vivo for studying memory formation. In order to identify genes with potential relevance for memory formation we used mouse organotypic hippocampal slice cultures in which chemical LTD was induced by applications of 3,5-dihydroxyphenylglycine (DHPG). The induction of chemical LTD was robust, as monitored electrophysiologically. Gene expression analysis after chemical LTD induction was performed using cDNA microarrays containing >7,000 probes. The DHPG-induced expression of immediate early genes (c-fos, junB, egr1 and nr4a1) was subsequently verified by TaqMan polymerase chain reaction. Bioinformatic analysis suggested a common regulator element [serum response factor (SRF)/Elk-1 binding sites] within the promoter region of these genes. Indeed, here we could show a DHPG-dependent binding of SRF at the SRF response element (SRE) site within the promoter region of c-fos and junB. However, SRF binding to egr1 promoter sites was constitutive. The phosphorylation of the ternary complex factor Elk-1 and its localization in the nucleus of hippocampal neurones after DHPG treatment was shown by immunofluorescence using a phosphospecific antibody. We suggest that LTD leads to SRF/Elk-1-regulated gene expression of immediate early transcription factors, which could in turn promote a second broader wave of gene expression.


Subject(s)
Genes, Immediate-Early/genetics , Hippocampus/metabolism , Long-Term Synaptic Depression/genetics , Serum Response Factor/genetics , Transcriptional Activation/genetics , ets-Domain Protein Elk-1/genetics , Animals , Binding Sites/genetics , Excitatory Amino Acid Agonists/pharmacology , Gene Expression Regulation/genetics , Glycine/analogs & derivatives , Glycine/pharmacology , Mice , Mice, Inbred C57BL , Organ Culture Techniques , Promoter Regions, Genetic/genetics , Proto-Oncogene Proteins c-fos/genetics , Proto-Oncogene Proteins c-fos/metabolism , Proto-Oncogene Proteins c-jun/genetics , Proto-Oncogene Proteins c-jun/metabolism , Resorcinols/pharmacology
4.
Mol Cell Biol ; 26(8): 2936-46, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16581769

ABSTRACT

Synaptic activity-dependent de novo gene transcription is crucial for long-lasting neuronal plasticity and long-term memory. In a forebrain neuronal conditional NF-kappaB-deficient mouse model, we demonstrate here that the transcription factor NF-kappaB regulates spatial memory formation, synaptic transmission, and plasticity. Gene profiling experiments and analysis of regulatory regions identified the alpha catalytic subunit of protein kinase A (PKA), an essential memory regulator, as a new NF-kappaB target gene. Consequently, NF-kappaB inhibition led to a decrease in forskolin-induced CREB phosphorylation. Collectively, these results disclose a novel hierarchical transcriptional network involving NF-kappaB, PKA, and CREB that leads to concerted nuclear transduction of synaptic signals in neurons, accounting for the critical function of NF-kappaB in learning and memory.


Subject(s)
Cyclic AMP Response Element-Binding Protein/metabolism , Cyclic AMP-Dependent Protein Kinases/metabolism , Memory/physiology , NF-kappa B/physiology , Synaptic Transmission/physiology , Animals , Cells, Cultured , Colforsin/pharmacology , Cyclic AMP Response Element-Binding Protein/genetics , Electrophoretic Mobility Shift Assay , Electrophysiology , Gene Expression Profiling , Hippocampus/cytology , Hippocampus/physiology , Immunohistochemistry , Male , Mice , Mice, Transgenic , Phosphorylation/drug effects
5.
BMC Genomics ; 4(1): 46, 2003 Nov 25.
Article in English | MEDLINE | ID: mdl-14641910

ABSTRACT

BACKGROUND: Tumor necrosis factor alpha (TNF) is able to induce a variety of biological responses in the nervous system including inflammation and neuroprotection. Human astrocytoma cells U373 have been widely used as a model for inflammatory cytokine actions in the nervous system. Here we used cDNA microarrays to analyze the time course of the transcriptional response from 1 h up to 12 h post TNF treatment in comparison to untreated U373 cells. TNF activated strongly the NF-kappaB transcriptional pathway and is linked to other pathways via the NF-kappaB target genes JUNB and IRF-1. Part of the TNF-induced gene expression could be inhibited by pharmacological inhibition of NF-kappaB with pyrrolidine-dithiocarbamate (PDTC). NF-kappaB comprises a family of transcription factors which are involved in the inducible expression of genes regulating neuronal survival, inflammatory response, cancer and innate immunity. RESULTS: In this study we show that numerous genes responded to TNF (> 880 from 7500 tested) with a more than two-fold induction rate. Several novel TNF-responsive genes (about 60% of the genes regulated by a factor > or = 3) were detected. A comparison of our TNF-induced gene expression profiles of U373, with profiles from 3T3 and Hela cells revealed a striking cell-type specificity. SCYA2 (MCP-1, CCL2, MCAF) was induced in U373 cells in a sustained manner and at the highest level of all analyzed genes. MCP-1 protein expression, as monitored with immunofluorescence and ELISA, correlated exactly with microarray data. Based on these data and on evidence from literature we suggest a model for the potential neurodegenerative effect of NF-kappaB in astroglia: Activation of NF-kappaB via TNF results in a strongly increased production of MCP-1. This leads to a exacerbation of neurodegeneration in stoke or Multiple Sclerosis, presumably via infiltration of macrophages. CONCLUSIONS: The vast majority of genes regulated more than 3-fold were previously not linked to tumor necrosis factor alpha as a search in published literature revealed. Striking co-regulation for several functional groups such as proteasome and ribosomal proteins were detected.


Subject(s)
Gene Expression Profiling , Oligonucleotide Array Sequence Analysis/methods , Tumor Necrosis Factor-alpha/pharmacology , Cell Line, Tumor/drug effects , Cell Line, Tumor/metabolism , Chemokine CCL2/genetics , Chemokine CCL2/metabolism , Cluster Analysis , Enzyme-Linked Immunosorbent Assay , Gene Expression Regulation, Neoplastic/drug effects , Glioblastoma/genetics , Glioblastoma/metabolism , Glioblastoma/pathology , Humans , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...